Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of a Novel Infant Formula on Immunity, Gut Health and Safety: A Multicenter, Double-blind, Randomized, Controlled Trial

NCT06686433 is registered in ClinicalTrials.gov with Biostime (Guangzhou) Health Products Limited as lead sponsor.

NCT NCT06686433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06686433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of a Novel Infant Formula on Immunity, Gut Health and Safety: A Multicenter, Double-blind, Randomized, Controlled Trial
Lead sponsor
Biostime (Guangzhou) Health Products Limited
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2025
Completion date
August 17, 2026
Enrollment
342 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

healthy term infant